AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 26040200
Drug: Double antibiotic
RxNorm normalized name: Double Antibiotic
DrugBank: Polymyxin B (DB00781)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Double antibiotic paste (DAP) 1 mg ml(‐1)
Trial: 29428121
Drug: Traditional intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Traditional intervention (psychiatry and medicine only)
Trial: 365670
Drug: Simethicone solution
RxNorm normalized name: Simethicone
DrugBank: Simethicone (DB09512)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simethicone solution before peroral endoscopy
Trial: 22595362
Drug: Levetiracetam (LEV)
RxNorm normalized name: Levetiracetam
DrugBank: Levetiracetam (DB01202)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Levetiracetam (LEV) 2000 mg/day
Trial: 22595362
Drug: Lamotrigine (LTG)
RxNorm normalized name: Lamotrigine
DrugBank: Lamotrigine (DB00555)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lamotrigine (LTG) 200 mg/day
Trial: 28189575
Drug: Active treatment
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active treatment (duloxetine or fluoxetine)
Trial: 26114240
Drug: Aripiprazole lauroxil
RxNorm normalized name: Aripiprazole lauroxil
DrugBank: Aripiprazole lauroxil (DB14185)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aripiprazole lauroxil 882 mg
Trial: 25801872
Drug: Intensive treatment
RxNorm normalized name: Head & Shoulders Intensive Treatment
DrugBank: Selenium Sulfide (DB00971)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive treatment (target SBP <140 mm Hg)
Trial: 23446088
Drug: NGX-4010 treatment
RxNorm normalized name: benzoyl peroxide
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: NGX-4010 treatment
Trial: 23289548
Drug: Omega-3 fatty
RxNorm normalized name: Omega-3 fatty acid
DrugBank: Omega-3 fatty acids (DB11133)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omega-3 fatty acid supplementation (1,470 mg docosahexaenoic acid and 147 mg eicosapentaenoic acid daily)
Trial: 6428372
Drug: Lithium carbonate
RxNorm normalized name: Lithium Carbonate
DrugBank: Lithium carbonate (DB14509)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lithium carbonate (mean dose, 1,166 mg/day)
Trial: 30887607
Drug: Zoledronate 5
RxNorm normalized name: Zoledronic Acid
DrugBank: Zoledronic acid (DB00399)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Zoledronate 5 mg
Trial: 29530340
Drug: Topical SR-T100
RxNorm normalized name: SR 121463
DrugBank: SR 121463 (DB05455)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical SR-T100 gel
Trial: 17263737
Drug: Intranasal clonidine
RxNorm normalized name: Clonidine
DrugBank: Clonidine (DB00575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intranasal clonidine 4 microg/kg
Trial: 9660042
Drug: Oral clonidine
RxNorm normalized name: Clonidine
DrugBank: Clonidine (DB00575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral clonidine 4 microg/kg
Trial: 1728876
Drug: Oral clonidine
RxNorm normalized name: Clonidine
DrugBank: Clonidine (DB00575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral clonidine
Trial: 16863518
Drug: Systemic Glucantime
RxNorm normalized name: Glucantim
DrugBank: Meglumine antimoniate (DB13732)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Systemic Glucantime (20 mg pentavalent antimony/kg/day) plus pentoxifylline (400 mg three times daily) for 20 days
Trial: 8033141
Drug: Combined therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined therapy with M‐CSF and gamma‐IFN
Trial: 24191305
Drug: Both dual
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both dual therapy and monotherapy
Trial: 26607361
Drug: Intravenous regadenoson
RxNorm normalized name: Regadenoson
DrugBank: Regadenoson (DB06213)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous regadenoson 400 μg (2 doses)
Trial: 28841916
Drug: Surgery first
RxNorm normalized name: Cow first milk
DrugBank: Bos taurus colostrum (DB19249)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgery first (control group) followed by adjuvant chemotherapy (six cycles gemcitabine and capecitabine)
Trial: 28841916
Drug: Neoadjuvant chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant chemotherapy (four cycles FOLFIRINOX) followed by resection
Trial: 11812877
Drug: Ferric citrate
RxNorm normalized name: Ferric Citrate
DrugBank: Ferric sodium citrate (DB13771)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ferric citrate (3 g/day)
Trial: 25043337
Drug: RBP-7000 at
RxNorm normalized name: AT-III
DrugBank: Antithrombin III human (DB11598)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RBP-7000 at 60 mg
Trial: 25043337
Drug: RBP-7000 at
RxNorm normalized name: AT-III
DrugBank: Antithrombin III human (DB11598)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RBP-7000 at 90 mg
Trial: 21729308
Drug: Intravenous near-isotonic
RxNorm normalized name: sodium chloride
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous near-isotonic solution (0.81% sodium chloride in glucose)
Trial: 8370085
Drug: Nonfloating (NF)
RxNorm normalized name: NFS-02
DrugBank: NFS-02 (DB18422)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonfloating (NF) hydrophilic matrix capsules
Trial: 12966478
Drug: Parecoxib sodium
RxNorm normalized name: parecoxib sodium
DrugBank: Parecoxib (DB08439)
FDA approved: no
EMA approved: yes
PMDA approved: no
Description: Parecoxib sodium 50 mg
Trial: 31060106
Drug: Activities of
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Activities of Daily Living (ADL) III (disabled in some basic ADL)
Trial: 20502641
Drug: Oral polio
RxNorm normalized name: Oral Polio Vaccine
DrugBank: Oral Polio Vaccine (DB15864)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral polio vaccine (OPV) with BCG
Trial: 23496375
Drug: Itraconazole 400
RxNorm normalized name: Itraconazole
DrugBank: Itraconazole (DB01167)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Itraconazole 400 mg daily for 6 months plus supportive therapy
Trial: 1773908
Drug: Chlorpheniramine maleate
RxNorm normalized name: Chlorpheniramine Maleate
DrugBank: Chlorpheniramine (DB01114)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorpheniramine maleate 12 mg
Trial: 31178152
Drug: 12-month trastuzumab
RxNorm normalized name: trastuzumab
DrugBank: Trastuzumab (DB00072)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: 12-month trastuzumab treatment
Trial: 31178152
Drug: 6-month trastuzumab
RxNorm normalized name: leuprolide
DrugBank: Leuprolide (DB00007)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6-month trastuzumab treatment
Trial: 15817604
Drug: Paclitaxel 175
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paclitaxel 175 mg/m² + carboplatin AUC 5 (arm B)
Trial: 22806399
Drug: Apremilast 40
RxNorm normalized name: Apremilast
DrugBank: Apremilast (DB05676)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Apremilast 40 mg once per day
Trial: 25171902
Drug: Enzalutamide 160
RxNorm normalized name: Enzalutamide
DrugBank: Enzalutamide (DB08899)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Enzalutamide 160 mg/d
Trial: 10829042
Drug: Subcutaneous amifostine
RxNorm normalized name: Amifostine
DrugBank: Amifostine (DB01143)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Subcutaneous amifostine 500 mg before each radiotherapy fraction
Trial: 17095328
Drug: Tdap vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tdap vaccine
Trial: 23660289
Drug: Intra-arterial abciximab
RxNorm normalized name: methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intra-arterial abciximab infusion
Trial: 16804032
Drug: Radiofrequency exposure
RxNorm normalized name: Bacillus anthracis strain V770-NP1-R antigens
DrugBank: Anthrax vaccine (DB11003)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiofrequency exposure (1,800 MHz, Specific Absorption Rate 2 W/kg) with mitogenic stimulation
Trial: 7785755
Drug: Propofol anesthesia
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol anesthesia (1.0-2.5 mg/kg for induction, 4-12 mg/kg for maintenance)
Trial: 20799264
Drug: Certolizumab pegol
RxNorm normalized name: Certolizumab Pegol
DrugBank: Certolizumab pegol (DB08904)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Certolizumab pegol 200 mg every other week plus methotrexate
Trial: 24318743
Drug: Oral phenoxodiol
RxNorm normalized name: Phenoxodiol
DrugBank: Idronoxil (DB04915)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral phenoxodiol (PXD) plus AUC2-carboplatin
Trial: 7527112
Drug: Tranexamic acid
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tranexamic acid (total dose 20 mg/kg body weight)
Trial: 29439147
Drug: IONIS-PTP-1BRx 200
RxNorm normalized name: IONIS SOD1Rx
DrugBank: Tofersen (DB14782)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IONIS-PTP-1BRx 200 mg once weekly for 26 weeks
Trial: 26385134
Drug: Cold gel
RxNorm normalized name: Deep Freeze Cold Gel
DrugBank: Chlorpheniramine (DB01114)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cold gel pack (3-5 °C)
Trial: 25426896
Drug: Ozonated oil
RxNorm normalized name: ozone
DrugBank: Ozone (DB12510)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ozonated oil (2 mL daily for 1 week)
Trial: 8437319
Drug: Early parenteral
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early parenteral nutrition (EPN)
Trial: 23700938
Drug: Standard PD
RxNorm normalized name: PD-0299685
DrugBank: PD-0299685 (DB15264)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard PD solutions (CAPDP-1)
Trial: 8404101
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration of a polyvalent bacterial extract (BE).
Trial: 22952213
Drug: Darexaban 15
RxNorm normalized name: Darexaban
DrugBank: Darexaban (DB12289)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Darexaban 15 mg bid
Trial: 26342502
Drug: Oral ivermectin
RxNorm normalized name: Ivermectin
DrugBank: Ivermectin (DB00602)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral ivermectin 200 μg/kg body weight
Trial: 23263729
Drug: Carbon-ion therapy
RxNorm normalized name: carbonate ion
DrugBank: Carbonate ion (DB14531)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbon-ion therapy with compensating boli designed for PTV1 and PTV2 at peak-exhalation phase
Trial: 3181102
Drug: Ascorbic acid
RxNorm normalized name: Ascorbic Acid
DrugBank: Ascorbic acid (DB00126)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ascorbic acid 30 mg
Trial: 10480041
Drug: Guided self-hypnotic
RxNorm normalized name: Synotic
DrugBank: Fluocinolone acetonide (DB00591)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Guided self-hypnotic relaxation using a standardized protocol and script
Trial: 24472402
Drug: SB-705498 12
RxNorm normalized name: SB-705498
DrugBank: SB-705498 (DB11883)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SB-705498 12 mg
Trial: 9554801
Drug: Cilostazol 200
RxNorm normalized name: Cilostazol
DrugBank: Cilostazol (DB01166)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cilostazol 200 mg orally daily for 2 weeks
Trial: 7918290
Drug: Oral albendazole
RxNorm normalized name: Albendazole
DrugBank: Albendazole (DB00518)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral albendazole 15 mg/kg once daily for 1 month
Trial: 24036846
Drug: Nilotinib 400
RxNorm normalized name: Nilotinib
DrugBank: Nilotinib (DB04868)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nilotinib 400 mg p.o.
Trial: 24036846
Drug: Calcium carbonate
RxNorm normalized name: Calcium Carbonate
DrugBank: Calcium carbonate (DB06724)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium carbonate 4,000 mg (4 X Tums Ultra 1000®) p.o. 15 min prior to nilotinib dose.
Trial: 15342446
Drug: Current hormone
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Current hormone replacement therapy (HRT) users
Trial: 8314169
Drug: sustained-release bezafibrate
RxNorm normalized name: bezafibrate
DrugBank: Bezafibrate (DB01393)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sustained-release bezafibrate 400 mg (n = 21)
Trial: 25348661
Drug: Pegylated interferon
RxNorm normalized name: Pegylated interferon alfa-2a
DrugBank: Peginterferon alfa-2a (DB00008)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pegylated interferon (Peg-IFN) add-on therapy
Trial: 25574800
Drug: Propofol at
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol at an effect-site concentration of 2.5 µg/mL combined with remifentanil (0.25 to 0.35 μg/kg/min) and cisatracurium (0.03 to 0.04 mg/kg/h)
Trial: 31937137
Drug: Best medical
RxNorm normalized name: calcium polycarbophil
DrugBank: Calcium polycarbophil (DB14684)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Best medical therapy + structured exercise therapy (nonrevascularization group)
Trial: 16840657
Drug: albumin infusion
RxNorm normalized name: Albumin Aggregated
DrugBank: Albumin Aggregated (DB14230)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: albumin infusion (control)
Trial: 23430192
Drug: Insulin glargine
RxNorm normalized name: Insulin Glargine
DrugBank: Insulin glargine (DB00047)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Insulin glargine (GLA) at bedtime
Trial: 23430192
Drug: Metformin (MET)
RxNorm normalized name: metformin / pioglitazone Oral Tablet [Actoplus Met]
DrugBank: Metformin (DB00331)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Metformin (MET) 1,000 mg b.i.d.
Trial: 9828987
Drug: Graded exercise
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Graded exercise and placebo drug
Trial: 2901668
Drug: Intravenous immunoglobulin
RxNorm normalized name: Intravenous immunoglobulin (IVIg)
DrugBank: Human immunoglobulin G (DB00028)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous immunoglobulin G (400 mg per kilogram of body weight) every three weeks for one year
Trial: 24448652
Drug: Omeprazole/sodium bicarbonate
RxNorm normalized name: OMEPRAZOLE/SODIUM BICARBONATE
DrugBank: Sodium bicarbonate (DB01390)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Omeprazole/sodium bicarbonate (Zegerid(®)) 40 mg once daily for 8 weeks (morning dosing)
Trial: 11477842
Drug: Salvia Miltiorrhizae
RxNorm normalized name: Salvia miltiorrhiza root extract
DrugBank: Salvia miltiorrhiza root (DB14337)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salvia Miltiorrhizae Composita (SMC) administered intravenously (16 ml) before NTG utilization
Trial: 8232870
Drug: Gadodiamide injection
RxNorm normalized name: Gadodiamide
DrugBank: Gadodiamide (DB00225)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Gadodiamide injection (Omniscan)
Trial: 29978932
Drug: Delayed VT
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Delayed VT therapy (Arm C)
Trial: 9182114
Drug: Doxycycline 300
RxNorm normalized name: Doxycycline
DrugBank: Doxycycline (DB00254)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Doxycycline 300 mg as a single dose on admission
Trial: 28658329
Drug: Non-adherent Ibuprofen
RxNorm normalized name: Ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Non-adherent Ibuprofen foam dressing (IFD)
Trial: 24619855
Drug: Intravenous fentanyl
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravenous fentanyl (F)
Trial: 20627032
Drug: Ilaprazole 5
RxNorm normalized name: ilaprazole
DrugBank: Ilaprazole (DB11964)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ilaprazole 5 mg/d
Trial: 29320597
Drug: SPF 70
RxNorm normalized name: Coppertone Kids Sunscreen SPF 70
DrugBank: Homosalate (DB11064)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: SPF 70 sunscreen applied at 2 mg/cm2
Trial: 14728888
Drug: Methylprednisolone pulse
RxNorm normalized name: Methylprednisolone
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methylprednisolone pulse therapy (MPT) intravenously (30 mg/kg) for 3 days followed by oral prednisone
Trial: 10411811
Drug: Oral methotrexate
RxNorm normalized name: Methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral methotrexate (chosen by women in phase 2)
Trial: 8873488
Drug: Multidisciplinary intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Multidisciplinary intervention (comprehensive patient education, dietary and social service consultations, medication review, intensive postdischarge follow‐up)
Trial: 804914
Drug: Cromoglycic acid
RxNorm normalized name: Cromoglycic acid
DrugBank: Cromoglicic acid (DB01003)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cromoglycic acid tablets
Trial: 29987587
Drug: Bilateral botulinum
RxNorm normalized name: Clostridium botulinum
DrugBank: Clostridium botulinum (DB14223)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bilateral botulinum toxin (BT) therapy using CBTX‐A, standard doses on affected side, one-third doses on non-affected side
Trial: 31468402
Drug: Dietary taurine
RxNorm normalized name: Taurine
DrugBank: Taurine (DB01956)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Dietary taurine supplementation (3 g of taurine)
Trial: 24608161
Drug: GnRH agonist
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH agonist (Goserelin)
Trial: 24608161
Drug: GnRH agonist
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH agonist + GnRH antagonist (Goserelin and Cetrorelix)
Trial: 8147338
Drug: Ferrous sulphate
RxNorm normalized name: Ferrous sulphate
DrugBank: Ferrous fumarate (DB14491)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ferrous sulphate (60 or 120 mg Fe/d)
Trial: 30066465
Drug: Dexamethasone group
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Dexamethasone group (20 mL bupivacaine 0.5% + 2 mL dexamethasone 8 mg)
Trial: 30213173
Drug: Preoperative parecoxib
RxNorm normalized name: parecoxib
DrugBank: Parecoxib (DB08439)
FDA approved: no
EMA approved: yes
PMDA approved: no
Description: Preoperative parecoxib administration (40 mg before skin incision and at 12 and 24 hours after the first dose)
Trial: 21455724
Drug: Zinc gluconate
RxNorm normalized name: Zinc Gluconate
DrugBank: Zinc gluconate (DB11248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Zinc gluconate salt (10 mg, twice daily until day seven of age)
Trial: 11955846
Drug: Gamma intracoronary
RxNorm normalized name: Gamma Cyclodextrin
DrugBank: Gamma cyclodextrin (DB19173)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gamma intracoronary radiation therapy (ICRT)
Trial: 15497666
Drug: Clarithromycin suspension
RxNorm normalized name: Clarithromycin
DrugBank: Clarithromycin (DB01211)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clarithromycin suspension 250 mg/5 mL (Klaromin)
Trial: 18388088
Drug: Amlodipine 5
RxNorm normalized name: amlodipine 5 MG
DrugBank: Amlodipine (DB00381)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amlodipine 5 mg/d and indapamide 2.5 mg/d, increasing amlodipine to 10 mg/d
Trial: 19105585
Drug: Cilomilast 15
RxNorm normalized name: CILOMILAST
DrugBank: Cilomilast (DB03849)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cilomilast 15 mg, twice daily for 24 weeks
Trial: 9316524
Drug: Transdermal nitroglycerin
RxNorm normalized name: nitroglycerin Transdermal System
DrugBank: Nitroglycerin (DB00727)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal nitroglycerin (TD‐NTG) 0.2 to 0.4 mg/h
Trial: 8566980
Drug: Podophyllotoxin cream
RxNorm normalized name: podophyllotoxin
DrugBank: Podofilox (DB01179)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Podophyllotoxin cream 0.5%
Trial: 19767384
Drug: Conventional insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conventional insulin pump therapy (CSII group) with protocol compliance
Trial: 22430976
Drug: Single administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Single administration of 100 mg of ferroquine
Trial: 12208409
Drug: Omapatrilat 40
RxNorm normalized name: OMAPATRILAT
DrugBank: Omapatrilat (DB00886)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omapatrilat 40 mg/day
Trial: 8269450
Drug: Dinoprostone cervical
RxNorm normalized name: Dinoprostone
DrugBank: Dinoprostone (DB00917)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Dinoprostone cervical gel 0.5 mg administered 12 hours prior to oxytocin induction
Trial: 9134079
Drug: Randomly assigned
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Randomly assigned to intensive group therapy
Trial: 21672211
Drug: Aerobic exercise
RxNorm normalized name: camphor
DrugBank: Camphor (DB01744)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aerobic exercise therapy (AET) + usual care
Trial: 23152592
Drug: Intranasal administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intranasal administration of oxytocin (OXT)
Trial: 29023327
Drug: Sodium bicarbonate
RxNorm normalized name: Sodium Bicarbonate
DrugBank: Sodium bicarbonate (DB01390)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium bicarbonate (NaHCO3) supplementation (0.2 g·kg)